2004
DOI: 10.1016/j.addbeh.2004.03.041
|View full text |Cite
|
Sign up to set email alerts
|

Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
82
1
4

Year Published

2008
2008
2022
2022

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 102 publications
(90 citation statements)
references
References 5 publications
3
82
1
4
Order By: Relevance
“…A co-occurring ADHD diagnosis is also associated with an earlier onset and more severe course of a SUD, poorer treatment adherence, more difficulty achieving treatment goals and progress in treatment, and higher rates of relapse (Carroll and Rounseville, 1993;Wise et al, 2001;Levin et al, 2004;Wilens et al, 1997). In a study by Kolpe and Carlson, (2007), the presence of clinically significant ADHD symptoms just prior to admission to a methadone program was associated with a poorer outcome in that program.…”
Section: Introductionmentioning
confidence: 99%
“…A co-occurring ADHD diagnosis is also associated with an earlier onset and more severe course of a SUD, poorer treatment adherence, more difficulty achieving treatment goals and progress in treatment, and higher rates of relapse (Carroll and Rounseville, 1993;Wise et al, 2001;Levin et al, 2004;Wilens et al, 1997). In a study by Kolpe and Carlson, (2007), the presence of clinically significant ADHD symptoms just prior to admission to a methadone program was associated with a poorer outcome in that program.…”
Section: Introductionmentioning
confidence: 99%
“…De acuerdo con nuestro objetivo principal, la prevalencia de comorbilidad psicopatológica de este estudio a lo largo de la vida ha sido alta (61,8%) en un rango parecido a los estudios realizados sobre distintos tipos de muestras con personas consumidoras de cocaína, tanto en tratamiento ambulatorio como de comunidades terapéuticas, así como en población no clínica (Adamson, Tood, Sellman, Huriwai y Porter, 2006;Arias et al, 2012;Herrero et al, 2008;Levín, Evans, Vosburg, Horton y Brooks, 2004;Mardsen, Gossop, Stewart, Rolfe y Farrell, 2000;Swendsen et al, 2010;Tortajada et al,2012). Tanto los estudios llevados a cabo en población general como los de muestras clínicas refieren que la prevalencia de la concurrencia de trastornos por consumo de sustancias y otras psicopatologías es elevada, situándose entre el 15-80% (Nocon, Bergé, Astals, Martín-Santos y Rodríguez-Llera et al, 2006;).…”
Section: Discussionunclassified
“…Three studies focused solely on cocaine users in their research (Levin et al, 2004;Vergara-Moragues et al, 2012;Vergara-Moragues, González-Saiz, Lozano, & Verdejo García, 2013), and further three focused solely on opiate dependence (Dekel, Benbenishty, & Amram, 2004;Keen, Oliver, Rowse, & Mathers, 2001;Zoccali et al, 2007). Of the multi-substance studies, the classification methodology was widely varied.…”
Section: Drug Use Patternsmentioning
confidence: 99%
“…Vergara-Moragues, González-Saiz, Lozano, and Verdejo García (2012) found that 68.3% of residents stayed in treatment more than 90 days. Finally, Levin, Evans, Vosburg, Horton, Brooks, and Ng (2004) reported mean lengths of stay in three groups; no Axis I diagnosis, other Axis I diagnosis and ADHD (Ms = 49.1 weeks, 59.2 weeks, and 37.4 weeks, respectively).…”
Section: Retention and Dropout As Well As Mean Length Of Stay In Treamentioning
confidence: 99%
See 1 more Smart Citation